Opportunity ID: 252437

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-14-501
Funding Opportunity Title: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 23
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 12, 2014
Last Updated Date:
Original Closing Date for Applications: May 28, 2014
Current Closing Date for Applications: May 28, 2014
Archive Date: Jun 28, 2014
Estimated Total Program Funding: $10,000,000
Award Ceiling: $400,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to continue follow-up of the Diabetes Prevention Program Outcomes Study (DPPOS) cohort through a cooperative agreement. The Diabetes Prevention Program (DPP) was a multi-center controlled clinical trial examining the efficacy of treatments to prevent or delay the development of type 2 diabetes in a population at high risk. The DPP demonstrated that either lifestyle change or the drug metformin could reduce the development of type 2 diabetes by 58% and 31%, respectively, compared with placebo. Following the end of DPP, the DPP cohort was enrolled in the DPPOS to determine the long-term effects of the DPP interventions on further diabetes development and microvascular complications. The primary purpose of this FOA is to continue follow-up of the DPPOS cohort to examine the effectiveness of early metformin treatment on the development of cardiovascular disease and cancer.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-501.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.847 FORMS-C Forms-C PKG00193873 Apr 28, 2014 May 28, 2014 View

Package 1

Mandatory forms

252437 RR_SF424_2_0-2.0.pdf

252437 PHS398_ResearchPlan_2_0-2.0.pdf

252437 PHS398_CoverPageSupplement_2_0-2.0.pdf

252437 RR_KeyPersonExpanded_2_0-2.0.pdf

252437 RR_OtherProjectInfo_1_3-1.3.pdf

252437 PerformanceSite_2_0-2.0.pdf

Optional forms

252437 RR_SubawardBudget30_1_3-1.3.pdf

252437 PlannedReport-1.0.pdf

252437 PHS398_CumulativeInclusionReport-1.0.pdf

252437 PHS398_ModularBudget_1_2-1.2.pdf

252437 RR_Budget_1_3-1.3.pdf

2025-07-09T09:46:58-05:00

Share This Post, Choose Your Platform!

About the Author: